Literature DB >> 9276365

Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment.

L S Burke1, K M Greven, W T McGuirt, D Case, H M Hoen, M Raben.   

Abstract

PURPOSE: Treatment and disease-related factors were analyzed for their influence on the outcome of patients treated definitively with irradiation (RT) for early glottic carcinoma. METHODS AND MATERIALS: One hundred two patients with stage T1 or T2 glottic carcinomas were treated definitively with RT from December 1983 through September 1993. Median follow-up time was 63 months. Factors analyzed for each patient included age, sex, stage, anterior commissure involvement, surgical alternative, histologic differentiation, field size, total dose, fraction size, and total treatment time. Survival analysis methods were employed to assess the effects of these factors on local control and complication rates.
RESULTS: The 5-year local control rates by stage were as follows: T1a, 92%; T1b, 80%; T2a, 94%; and T2b, 23%. By univariate analysis, factors found to have a significant impact on local control were stage, surgical alternative, fraction size, anterior commissure involvement, and overall treatment time. By multivariate analysis, stage, field size, and fraction size were the only significant factors that independently influenced local control.
CONCLUSION: The inferior control rate for stage T2b lesions has implications for treatment. Our study supports the conclusion of reports in the literature showing that low fraction size negatively influences outcome in patients with early glottic cancer.

Entities:  

Mesh:

Year:  1997        PMID: 9276365     DOI: 10.1016/s0360-3016(97)00150-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  11 in total

1.  Diagnosis of anterior commissure invasion in laryngeal cancer.

Authors:  Baris Naiboglu; Vefa Kinis; Sema Zer Toros; Tulay Erden Habesoglu; Ildem Deveci; Mehmet Surmeli; Erol Egeli
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-13       Impact factor: 2.503

Review 2.  Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review.

Authors:  Federico Maria Gioacchini; Michele Tulli; Shaniko Kaleci; Stefano Bondi; Mario Bussi; Massimo Re
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-09-19       Impact factor: 2.503

3.  Dynamic helical CT of T1 and T2 glottic carcinomas: predictive value for local control with radiation therapy.

Authors:  R Murakami; M Furusawa; Y Baba; R Nishimura; F Katsura; M Eura; K Masuyama; M Takahashi
Journal:  AJNR Am J Neuroradiol       Date:  2000-08       Impact factor: 3.825

4.  Definitive radiotherapy for T1 glottic squamous cell carcinoma: a 15-year Cruces University Hospital experience.

Authors:  J Cacicedo; F Casquero; O del Hoyo; A Gomez-Iturriaga; L Martinez-Indart; J L Lopez; P Bilbao
Journal:  Clin Transl Oncol       Date:  2013-03-22       Impact factor: 3.405

5.  Functional organ preservation in laryngeal and hypopharyngeal cancer.

Authors:  Petra Ambrosch; Asita Fazel
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2012-04-26

6.  Definitive radiotherapy for early (T1-T2) glottic squamous cell carcinoma: a 20 year Cleveland Clinic experience.

Authors:  Mohammad K Khan; Shlomo A Koyfman; Grant K Hunter; Chandana A Reddy; Jerrold P Saxton
Journal:  Radiat Oncol       Date:  2012-11-19       Impact factor: 3.481

7.  Long-Term Outcome of Definitive Radiotherapy for Early Glottic Cancer: Prognostic Factors and Patterns of Local Failure.

Authors:  Yu Jin Lim; Hong-Gyun Wu; Tack-Kyun Kwon; J Hun Hah; Myung-Whun Sung; Kwang Hyun Kim; Charn Il Park
Journal:  Cancer Res Treat       Date:  2015-02-13       Impact factor: 4.679

8.  Transoral laser microsurgery for early glottic cancer.

Authors:  Lisha McClelland; Esmond Carr; Tawakir Kamani; Jennifer Cade; Kate Young; Sean Mortimore
Journal:  ISRN Otolaryngol       Date:  2011-11-23

9.  Risk of Recurrence in Laryngeal Cancer.

Authors:  Jesper Brandstorp-Boesen; Ragnhild Sørum Falk; Jan Folkvard Evensen; Morten Boysen; Kjell Brøndbo
Journal:  PLoS One       Date:  2016-10-07       Impact factor: 3.240

10.  Survival and Prognostic Factors for Outcome after Radiotherapy for T2 Glottic Carcinoma.

Authors:  Martine Hendriksma; Marc A P van Ruler; Berit M Verbist; Martin A de Jong; Ton P M Langeveld; Peter Paul G van Benthem; Elisabeth V Sjögren
Journal:  Cancers (Basel)       Date:  2019-09-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.